Avalo Therapeutics, Inc. · NASDAQ:AVTX

Deep Track Capital, LP reported a 6.87% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Deep Track Capital, LP reported a 6.87% stake in Avalo Therapeutics, Inc., 3,610,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.87%
Shares
3,610,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP6.87%3,610,000
Deep Track Biotechnology Master Fund, Ltd.6.87%3,610,000
David Kroin6.87%3,610,000

Source

View original at SEC

Related